MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
24.49
+1.33 (5.74%)
Sep 26, 2024, 4:00 PM EDT - Market closed
MBX Biosciences Employees
MBX Biosciences had 27 employees as of December 31, 2023.
Employees
27
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,748,148
Market Cap
817.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bioventus | 970 |
| Alphatec Holdings | 839 |
| Arbutus Biopharma | 73 |
| Terns Pharmaceuticals | 66 |
| Dianthus Therapeutics | 53 |
| ArriVent BioPharma | 40 |
MBX News
- 10 days ago - MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 12 days ago - U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Seeking Alpha
- 13 days ago - MBX Biosciences shares surge 44% in blockbuster Nasdaq debut - Reuters
- 14 days ago - MBX Biosciences raises $163.2 mln in US IPO - Reuters
- 14 days ago - MBX Biosciences Announces Pricing of Initial Public Offering - GlobeNewsWire
- 17 days ago - MBX Biosciences Announces Launch of Initial Public Offering - GLOBE NEWSWIRE
- 4 weeks ago - MBX Biosciences IPO Registration Document (S-1) - SEC